What is she best known for?
The fields of study she is best known for:
The scientist’s investigation covers issues in Antibody, Virology, Molecular biology, Cytidine deaminase and Immunoglobulin class switching.
Her Antibody study is concerned with Immunology in general.
Her Virology research incorporates elements of Germline mutation, Heterologous, Germline and Priming, Antigen.
Her research in Molecular biology intersects with topics in Non-homologous end joining, DNA, DNA repair and Activation-induced deaminase.
The concepts of her DNA study are interwoven with issues in Mutation and Gene.
Her Activation-induced deaminase study integrates concerns from other disciplines, such as Immunoglobulin gene, microRNA and Chromosomal translocation.
Her most cited work include:
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals. (708 citations)
- MicroRNA-155 Suppresses Activation-Induced Cytidine Deaminase-Mediated Myc-Igh Translocation (407 citations)
- MicroRNA-155 Suppresses Activation-Induced Cytidine Deaminase-Mediated Myc-Igh Translocation (407 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Antibody, Virology, Monoclonal antibody, Virus and Immunology.
Anna Gazumyan combines subjects such as Immunity and Antigen with her study of Antibody.
The study incorporates disciplines such as Epitope, Serology, Potency and In vivo in addition to Virology.
Her research integrates issues of Mutation and Heterologous in her study of Immunology.
Her Mutation research is multidisciplinary, relying on both Cytidine deaminase and Immunoglobulin class switching.
She works mostly in the field of Immunoglobulin class switching, limiting it down to topics relating to Immunoglobulin gene and, in certain cases, Activation-induced deaminase, as a part of the same area of interest.
She most often published in these fields:
- Antibody (80.95%)
- Virology (57.14%)
- Monoclonal antibody (30.95%)
What were the highlights of her more recent work (between 2018-2021)?
- Antibody (80.95%)
- Virology (57.14%)
- Monoclonal antibody (30.95%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Antibody, Virology, Monoclonal antibody, Virus and Neutralization.
Her Antibody study contributes to a more complete understanding of Immunology.
Her biological study spans a wide range of topics, including Epitope, Serology and In vivo.
Her Epitope research includes elements of HBsAg and Hepatitis B virus.
Her work deals with themes such as Recombinant DNA and Vaccination, which intersect with Monoclonal antibody.
Her Antigen research includes themes of Germinal center, Immune system and Cell biology.
Between 2018 and 2021, her most popular works were:
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals. (708 citations)
- Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. (309 citations)
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. (200 citations)
In her most recent research, the most cited papers focused on:
Her primary scientific interests are in Antibody, Virology, Virus, Monoclonal antibody and Neutralization.
Her Antibody research is included under the broader classification of Immunology.
Anna Gazumyan has included themes like In vivo and Effector in her Virology study.
Her Monoclonal antibody research is multidisciplinary, incorporating perspectives in In vitro, Potency, Serology and Vaccination.
Her work deals with themes such as Vesicular stomatitis virus and Neutralizing antibody, which intersect with Neutralization.
As a part of the same scientific family, Anna Gazumyan mostly works in the field of Recombinant DNA, focusing on Titer and, on occasion, Immunization.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
